| Financial Year |
March 31 2023 |
| Monetary Funds |
113,738,374.55 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
286,517,965.90 |
| Advances to Suppliers |
46,636,740.76 |
| Other Receivables |
27,028,872.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
180,743,536.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,010,748.00 |
| Total Current Assets |
691,587,736.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
27,685,609.85 |
| Investment Properties |
-- |
| Fixed Assetes |
93,332,044.83 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,781,620.60 |
| R&D expenses |
-- |
| Goodwill |
801,749.07 |
| Long-Term Deferred and Prepaid Expenses |
265,632.30 |
| Deferred Income Tax Assets |
5,609,885.03 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
148,252,039.52 |
| Total Assets |
839,839,776.35 |
| Short-Term Loans |
8,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
377,318,194.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,203,340.64 |
| Taxes Payable |
10,987,495.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
289,953,547.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,046,014.00 |
| Other Current Liabilities |
6,659,126.96 |
| Sub-Total of Current Liabilities |
782,735,612.89 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
40,002.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,102,009.04 |
| Total Liabilities |
783,837,621.93 |
| Paid-In Capital(Or Share Stock) |
393,120,000.00 |
| Capital Surplus |
436,066,128.79 |
| Surplus Reserve |
40,137,457.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-780,306,413.65 |
| Minority Stockholder's Interest |
5,295,283.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
50,706,871.15 |
| Owner's Equity（Stockholder's Equity） |
56,002,154.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
839,839,776.35 |
